Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Der Nervenarzt
Erschienen in: Der Nervenarzt 10/2004

01.10.2004 | Übersichten

Spontane intrazerebrale Blutungen

verfasst von: Dr. A. Hug, A. Aschoff, S. Schwab

Erschienen in: Der Nervenarzt | Ausgabe 10/2004

Einloggen, um Zugang zu erhalten

Zusammenfassung

Spontane intrazerebrale Blutungen (ICBs) sind für ca. 8–15% aller Schlaganfälle verantwortlich, bei Patienten unter oraler Antikoagulation sogar bis zu 40%. Die Mortalität und Morbidität sind wesentlich höher als beim ischämischen Schlaganfall. Über die Behandlungsmöglichkeiten in der Akutsituation gibt es nur wenig Daten aus randomisierten kontrollierten Therapiestudien. In dieser Übersicht soll die aktuelle Datenlage zusammengefasst und darauf basierend sollen Empfehlungen zur Behandlung von ICBs gegeben werden.
Literatur
1.
Arakawa S, Saku Y, Ibayashi S et al. (1998) Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 29:1806–1809PubMed
2.
Ariesen MJ, Claus SP, Rinkel GJ et al. ( 2003) Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 34:2060–2065CrossRefPubMed
3.
Azzimondi G, Bassein L, Nonino F et al. (1995) Fever in acute stroke worsens prognosis. A prospective study. Stroke 26:2040–2043PubMed
4.
Babikian VL, Kase CS, Pessin MS et al. (1988) Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves. Stroke 19:407–408
5.
Bamford J, Sandercock P, Dennis M et al. (1990) A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project—1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 53:16–22PubMed
6.
Berger AR, Lipton RB, Lesser ML et al. (1988) Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 38:1363–1365PubMed
7.
Bertram M, Bonsanto M, Hacke W et al. (2000) Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol 247:209–214CrossRefPubMed
8.
Berwaerts J, Dijkhuizen RS, Robb OJ et al. (2000) Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke 31:2558–2562PubMed
9.
Boulis NM, Bobek MP, Schmaier A et al. (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113–1118PubMed
10.
Broderick JP, Adams HP Jr, Barsan W et al. (1999) Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30:905–915PubMed
11.
Broderick JP, Brott TG, Duldner JE et al. (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993PubMed
12.
Brott T, Broderick J, Kothari R et al. (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1–5PubMed
13.
Brott T, Thalinger K, Hertzberg V (1986) Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 17:1078–1083PubMed
14.
Burn J, Dennis M, Bamford J et al. (1997) Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 315:1582–1587PubMed
15.
Butler AC, Tait RC (1998) Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 103:1064–1066CrossRefPubMed
16.
Butler A, Tait RC (2004) Restarting oral anticoagulation after intracranial hemorrhage. Stroke 35:e5–6CrossRefPubMed
17.
Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635–641PubMed
18.
Dandapani BK, Suzuki S, Kelley RE et al. (1995) Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26:21–24PubMed
19.
Daverat P, Castel JP, Dartigues JF et al. (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6PubMed
20.
Dennis MS (2003) Outcome after brain haemorrhage. Cerebrovasc Dis 16(Suppl 1):9–13
21.
Diringer MN (1993) Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 21:1591–1603PubMed
22.
Eckman MH, Rosand J, Knudsen KA et al. (2003) Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34:1710–1716CrossRefPubMed
23.
Fernandes HM, Gregson B, Siddique S et al. (2000) Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 31:2511–2516PubMed
24.
Fiebach JB, Schellinger PD, Gass A et al. (2004) Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. A multicenter study on the validity of stroke imaging. Stroke 35:502–506CrossRefPubMed
25.
Fogelholm R, Avikainen S, Murros K (1997) Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28:1396–400PubMed
26.
Fogelholm R, Eskola K, Kiminkinen T et al. (1992). Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 55:1121–1124PubMed
27.
Franke CL, de Jonge J, van Swieten JC et al. (1990) Intracerebral hematomas during anticoagulant treatment. Stroke 21:726–730PubMed
28.
Franke CL, van Swieten JC, Algra A et al. (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657PubMed
29.
Fredriksson K, Norrving B, Stromblad LG (1992) Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23:972–977PubMed
30.
Fujii Y, Takeuchi S, Sasaki O et al. (1998) Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29:1160–1166PubMed
31.
Fujitsu K, Muramoto M, Ikeda Y et al. (1990) Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis. J Neurosurg 73:518–525PubMed
32.
Furlan AJ, Whisnant JP, Elveback LR (1979) The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol 5:367–373PubMed
33.
Gorter JW (1999) Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 53:1319–1327PubMed
34.
Halpin SF, Britton JA, Byrne JV et al. (1994) Prospective evaluation of cerebral angiography and computed tomography in cerebral haematoma. J Neurol Neurosurg Psychiatry 57:1180–1186PubMed
35.
Hardemark HG, Wesslen N, Persson L (1999) Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage. Cerebrovasc Dis 9:10–21CrossRefPubMed
36.
Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26:1471–1477PubMed
37.
Hemphill JC 3rd, Bonovich DC, Besmertis L et al. (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897PubMed
38.
Hylek EM, Go AS, Chang Y et al. (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026CrossRefPubMed
39.
Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897–902PubMed
40.
Inagawa T (2002) What are the actual incidence and mortality rates of intracerebral hemorrhage? Neurosurg Rev 25:237–246CrossRefPubMed
41.
Italian Acute Stroke study group (1988) Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 13:318–321
42.
Juvela S (1995) Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 52:1193–1200PubMed
43.
Kase CS, Robinson RK, Stein RW et al. (1985) Anticoagulant-related intracerebral hemorrhage. Neurology 35:943–948PubMed
44.
Kazui S, Naritomi H, Yamamoto H et al. (1996) Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1783–1787
45.
Klungel OH, Kaplan RC, Heckbert SR et al. (2000) Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 31:420–424PubMed
46.
Landefeld CS, Goldman L (1989) Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 87:144–152PubMed
47.
Leker RR, Abramsky O (1998) Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 50:1489–1491PubMed
48.
Lisk DR, Pasteur W, Rhoades H et al. (1994) Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 44:133–139PubMed
49.
Morgenstern LB, Demchuk AM, Kim DH et al. (2001) Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 56:1294–1299PubMed
50.
Mutlu N, Berry RG, Alpers BJ (1963) Massive cerebral hemorrhage. Clinical and pathological correlations. Arch Neurol 144:644–661PubMed
51.
Naff NJ, Carhuapoma JR, Williams MA et al. (2000) Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31:841–847PubMed
52.
Neal B, MacMahon S, Chapman N et al. (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists’ collaboration. Lancet 356:1955–1964PubMed
53.
Neau JP, Couderq C, Ingrand P et al. (2001) Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 11:195–200CrossRefPubMed
54.
Nilsson OG, Lindgren A, Brandt L et al. (2002) Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 97:531–536PubMed
55.
Nilsson OG, Lindgren A, Stahl N et al. (2000) Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 69:601–607CrossRefPubMed
56.
O’Donnell HC, Rosand J, Knudsen KA et al. (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342:240–245CrossRefPubMed
57.
Passero S, Rocchi R, Rossi S et al. (2002) Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 43:1175–1180CrossRefPubMed
58.
Perry HM Jr, Davis BR, Price TR et al. (2000) Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 284:465–471CrossRefPubMed
59.
Pfausler B, Spiss H, Beer R et al. (2003) Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 98:1040–1044PubMed
60.
Phan TG, Koh M, Wijdicks EF (2000) Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 57:1710–1713CrossRefPubMed
61.
Poungvarin N, Bhoopat W, Viriyavejakul A et al. (1987) Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 316:1229–1233PubMed
62.
Powers WJ, Zazulia AR, Videen TO et al. (2001) Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) intracerebral hemorrhage. Neurology 57:18–24CrossRefPubMed
63.
PROGRESS collaborative group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033–1041PubMed
64.
Qureshi AI, Tuhrim S, Broderick JP et al. (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344:1450–1460CrossRefPubMed
65.
Radberg JA, Olsson JE, Radberg CT (1991) Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22:571–576PubMed
66.
Reith J, Jorgensen HS, Pedersen PM et al. (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347:422–425PubMed
67.
Schellinger PD, Jansen O, Fiebach JB et al. (1999) A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage.Stroke 30:765–768PubMed
68.
Schmutzhard E, Engelhardt K, Beer R et al. (2002) Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med 30:2481–2488CrossRefPubMed
69.
Schwab S, Spranger M, Schwarz S et al. (1997) Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 48:1608–1613PubMed
70.
Schwarz S, Schwab S, Steiner HH et al. (1999) Fibrinolysis of intraventricular hematoma with rt-PA. Nervenarzt 70:123–130CrossRefPubMed
71.
Schwarz S, Hafner K, Aschoff A et al. (2000) Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 54:354–361PubMed
72.
SHEP cooperative research group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255–3264PubMed
73.
Sjoblom L, Hardemark HG, Lindgren A et al. (2001) Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 32:2567–2574PubMed
74.
Staessen JA, Fagard R, Thijs L et al. (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet 350:757–764PubMed
75.
Sudlow CL, Warlow CP (1997) Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International stroke incidence collaboration. Stroke 28:491–499PubMed
76.
Teernstra OP, Evers SM, Lodder J et al. (2003) Multicenter randomized controlled trial (SICHPA). Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34:968–974CrossRefPubMed
77.
Tellez H, Bauer RB (1973) Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 4:541–546PubMed
78.
The Stroke Prevention in Atrial Fibrillation Investigators (1996) Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 156:409–416CrossRefPubMed
79.
Thrift AG, McNeil JJ, Forbes A et al. (1996) Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke 27:2020–2025PubMed
80.
Thrift AG, McNeil JJ, Forbes A (1998) Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 31:1223–1229PubMed
81.
Wang JG, Staessen JA, Gong L et al. (2000) Chinese trial on isolated systolic hypertension in the elderly. Systolic hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 160:211–220CrossRefPubMed
82.
Wang JG, Staessen JA (2001) The benefit of treating isolated systolic hypertension. Curr Hypertens Rep 3:333–339PubMed
83.
Weimar C, Weber C, Wagner M et al. (2003) Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 15(1–2):29–36
84.
Wijdicks EF, Schievink WI, Brown RD et al. (1998) The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 42:769–773PubMed
85.
Wintzen AR, de Jonge H, Loeliger EA et al. (1984) The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 16:553–558PubMed
86.
Yasaka M, Minematsu K, Naritomi H, et al. (2003) Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 89:278–283PubMed
87.
Yu YL, Kumana CR, Lauder IJ et al. (1992) Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 23:967–971PubMed
88.
Zhu XL, Chan MS, Poon WS (1997) Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 28:1406–1409PubMed
Metadaten
Titel
Spontane intrazerebrale Blutungen
verfasst von
Dr. A. Hug
A. Aschoff
S. Schwab
Publikationsdatum
01.10.2004
Erschienen in
Der Nervenarzt / Ausgabe 10/2004
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-004-1737-0

Weitere Artikel der Ausgabe 10/2004

Der Nervenarzt 10/2004 Zur Ausgabe

Aktuelles

Cannabinoide bei multipler Sklerose

Übersichten

Differenzialdiagnose chronisch-entzündlicher Erkrankungen des Zentralnervensystems

Kasuistik

Hypokaliämische Lähmung bei Hyperthyreose

Originalien

Normierung der Brief Repeatable Battery of Neuropsychological Tests (BRB-N) für den deutschsprachigen Raum

Übersichten

Kortikale Repräsentation von Schmerz

Kasuistik

Leptomeningeale Tumorzellinfiltration als Erstmanifestation eines Immunozytoms (M. Waldenström)

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Bildnachweise